Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.31 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.30 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.30 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.30 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.30 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.30 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.30 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.30 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25146322 | 0.91 | KDM1A (0.44) | KDM1AEPHX1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL21432352 | 0.82 | KDM1A (0.37) | KDM1AEPHX1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL19346909 | 0.80 | KDM1A (0.36) | KDM1AEPHX1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL14219765 | 0.80 | — | — | |
| SCHEMBL16573360 | 0.80 | — | — | |
| SCHEMBL14204181 | 0.79 | — | — | |
| SCHEMBL8741216 | 0.78 | — | — | |
| SCHEMBL23373220 | 0.78 | KDM1A (0.35) | KDM1A | |
| SCHEMBL19080650 | 0.74 | DNM1 (0.42) | KDM1A | |
| SCHEMBL22645875 | 0.73 | MCL1 (0.39) | KDM1AMCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 195 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239805-A1 | AZA-YANG CYCLIZATION-BUCHNER AROMATIC RING EXPANSION: COLLECTIVE SYNTHESIS OF CYCLOHEPTATRIENE-CONTAINING AZETIDINE LACTONES | UNIVERSITY OF KANSAS | 2024-07-18 | — | — | US | disclosed |
| US-20240239805-A1 | AZA-YANG CYCLIZATION-BUCHNER AROMATIC RING EXPANSION: COLLECTIVE SYNTHESIS OF CYCLOHEPTATRIENE-CONTAINING AZETIDINE LACTONES | UNIVERSITY OF KANSAS | 2024-07-18 | — | — | US | disclosed |
| US-12024515-B2 | Kifunensine derivatives | UNIVERSITY OF KANSAS (US) | 2024-07-02 | — | — | US | disclosed |
| WO-2024077087-A2 | M24B AMINOPEPTIDASE INHIBITORS FOR CARDS INFLAMMASOME ACTIVATION | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2024-04-11 | — | — | WO | disclosed |
| WO-2024006287-A2 | ANTIVIRAL COMPOUNDS USEFUL AGAINST SARS-COV-2 | UNIVERSITY OF KANSAS (US) | 2024-01-04 | — | — | WO | disclosed |
| WO-2023239789-A1 | TRICYCLIC PHTHALAZINONE PARP INHIBITORS AND METHODS OF USE | VALO HEALTH, INC. (US) | 2023-12-14 | — | — | WO | disclosed |
| US-11834489-B2 | Methods for quantifying ligand efficacy in G-protein coupled receptors using single-molecule fluorescence energy transfer | CORNELL UNIVERSITY (US) | 2023-12-05 | — | — | US | disclosed |
| US-11834489-B2 | Methods for quantifying ligand efficacy in G-protein coupled receptors using single-molecule fluorescence energy transfer | CORNELL UNIVERSITY (US) | 2023-12-05 | — | — | US | disclosed |
| US-20230372550-A1 | MACROCYCLIC COMPLEXES OF ALPHA-EMITTING RADIONUCLIDES AND THEIR USE IN TARGETED RADIOTHERAPY OF CANCER | CORNELL UNIVERSITY (US) | 2023-11-23 | — | — | US | disclosed |
| US-20230372551-A1 | RADIOLABELED LIGANDS FOR TARGETED PET/SPECT IMAGING AND METHODS OF THEIR USE | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2023-11-23 | — | — | US | disclosed |
| US-20170260141-A1 | ANTAGONISTS OF THE KAPPA OPIOID RECEPTOR | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED | 2017-09-14 | — | — | US | disclosed |
| US-20170114050-A1 | N-Acylethanolamine Hydrolyzing Acid Amidase (NAAA) Inhibitors And Their Use Thereof | NORTHEASTERN UNIVERSITY | 2017-04-27 | — | — | US | disclosed |
| US-20170114050-A1 | N-Acylethanolamine Hydrolyzing Acid Amidase (NAAA) Inhibitors And Their Use Thereof | NORTHEASTERN UNIVERSITY | 2017-04-27 | — | — | US | disclosed |
| WO-2017053604-A1 | POTENT ANTIVIRAL PYRAZOLOPYRIDINE COMPOUNDS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-03-30 | — | — | WO | disclosed |
| US-20160377946-A1 | ELECTROCHROMIC THERMOPLASTICS, DEVICES, AND COMPOSITES | GENTEX CORPORATION | 2016-12-29 | — | — | US | disclosed |
| US-20160194284-A1 | ALLOSTERIC MODULATORS OF THE CANNABINOID 1 RECEPTOR | NORTHEASTERN UNIVERSITY (US) | 2016-07-07 | — | — | US | disclosed |
| US-20160194284-A1 | ALLOSTERIC MODULATORS OF THE CANNABINOID 1 RECEPTOR | NORTHEASTERN UNIVERSITY (US) | 2016-07-07 | — | — | US | disclosed |
| US-20160146751-A1 | MEMBRANES FOR USE IN ELECTROCHEMICAL SENSORS AND ASSOCIATED DEVICES | GENTEX CORPORATION | 2016-05-26 | — | — | US | disclosed |
| WO-2015179190-A1 | N-ACYLETHANOLAMINE HYDROLYZING ACID AMIDASE (NAAA) INHIBITORS AND THEIR USE THEREOF | NORTHEASTERN UNIVERSITY (US) | 2015-11-26 | — | — | WO | disclosed |
| WO-2015027160-A2 | ALLOSTERIC MODULATORS OF THE CANNIBINOID 1 RECEPTOR | NORTHEASTERN UNIVERSITY (US) | 2015-02-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239805-A1 | AZA-YANG CYCLIZATION-BUCHNER AROMATIC RING EXPANSION: COLLECTIVE SYNTHESIS OF CYCLOHEPTATRIENE-CONTAINING AZETIDINE LACTONES | AZI2, NISCH, TET2 | KDM1A 817/4885MMP1 2549/4885MMP2 1532/4885 |
| US-20160194284-A1 | ALLOSTERIC MODULATORS OF THE CANNABINOID 1 RECEPTOR | CNR1, CNR2, GPR119 | KDM1A 1076/4885MMP1 4846/4885MMP2 4507/4885 |
| US-11834489-B2 | Methods for quantifying ligand efficacy in G-protein coupled receptors using single-molecule fluorescence energy transfer | GPR3, GPR4, GPR68 | KDM1A 4293/4885MMP1 4793/4885MMP2 4858/4885 |
| US-20230372550-A1 | MACROCYCLIC COMPLEXES OF ALPHA-EMITTING RADIONUCLIDES AND THEIR USE IN TARGETED RADIOTHERAPY OF CANCER | PSMA7, SLC39A14, ARCN1 | KDM1A 4019/4885MMP1 3566/4885MMP2 2221/4885 |
| US-20170114050-A1 | N-Acylethanolamine Hydrolyzing Acid Amidase (NAAA) Inhibitors And Their Use Thereof | NAAA, NAT1, NIT2 | KDM1A 1883/4885MMP1 1217/4885MMP2 384/4885 |
| US-20170260141-A1 | ANTAGONISTS OF THE KAPPA OPIOID RECEPTOR | OPRK1, OPRD1, OPRL1 | KDM1A 3674/4885MMP1 4352/4885MMP2 2895/4885 |
| US-20230372551-A1 | RADIOLABELED LIGANDS FOR TARGETED PET/SPECT IMAGING AND METHODS OF THEIR USE | MPI, FOLH1, GRPR | KDM1A 4879/4885MMP1 3307/4885MMP2 2525/4885 |
| US-12024515-B2 | Kifunensine derivatives | MAN2B1, MAN2A1, MANBA | KDM1A 957/4885MMP1 688/4885MMP2 196/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.